<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03630393</url>
  </required_header>
  <id_info>
    <org_study_id>1306218</org_study_id>
    <nct_id>NCT03630393</nct_id>
  </id_info>
  <brief_title>Ultralow Versus Standard Pneumoperitoneum Pressure</brief_title>
  <acronym>Ultralow</acronym>
  <official_title>Randomized Study of Ultralow Versus Standard Pneumoperitoneum Pressure During Robotic Prostatectomy Using the AirSealÂ® Insufflation System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OhioHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ConMed Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>OhioHealth</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to compare insufflation pressures during robotic assisted laparoscopic&#xD;
      prostatectomy (RALP). Standard pressure is typically 15 mmHg, while in a previous study the&#xD;
      investigators determined that 6 mmHg is possible routinely. Therefore, the investigators plan&#xD;
      to compare the clinical outcomes of participants at a pneumoperitoneal pressure of 15 versus&#xD;
      6 mmHg.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators to examine the impact of low pressure during robotic assisted laparoscopic&#xD;
      prostatectomy (RALP) with the intention of identifying whether lower pressures might benefit&#xD;
      participants. The investigators hypothesize that a low insufflation pressure may provide an&#xD;
      improvement in postoperative pain and abdominal distension in addition to potential&#xD;
      physiologic benefits, and that these factors might then allow a shorter hospital stay. The&#xD;
      investigators previously initiated a protocol in September of 2016 (IRB# 1066864) to perform&#xD;
      RALPs at an insufflation pressure of 6 mmHg with the intention of increasing the pressure as&#xD;
      needed on an individual participant level. In order to determine whether this might allow&#xD;
      earlier discharge when successful, the investigators began allowing for same-day discharge in&#xD;
      participants meeting appropriate criteria. Having now demonstrated feasibility in over 300&#xD;
      consecutive participants using this ultralow pneumoperitoneum protocol, the investigators now&#xD;
      plan to conduct a randomized trial to compare a pressure of 6 mmHg with participants having&#xD;
      RALP at a standard pressure of 15 mmHg to determine whether there is a true benefit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI left institution&#xD;
  </why_stopped>
  <start_date type="Actual">May 9, 2019</start_date>
  <completion_date type="Actual">February 10, 2021</completion_date>
  <primary_completion_date type="Actual">February 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain medication use</measure>
    <time_frame>Through 1 week postoperatively</time_frame>
    <description>Morphine equivalents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores</measure>
    <time_frame>Through discharge postoperatively</time_frame>
    <description>Pain scores on a 0-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative ventilation</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Average tidal volume (ml)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Pressure 6 mmHg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pneumoperitoneum Pressure 6 mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure 15 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pneumoperitoneum Pressure 15 mmHg</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pneumoperitoneum Pressure 6 mmHg</intervention_name>
    <description>A pneumoperitoneum insufflation pressure of 6 mmHg will be used during RALP.</description>
    <arm_group_label>Pressure 6 mmHg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pneumoperitoneum Pressure 15 mmHg</intervention_name>
    <description>A pneumoperitoneum insufflation pressure of 15 mmHg will be used during RALP.</description>
    <arm_group_label>Pressure 15 mmHg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 or older&#xD;
&#xD;
          2. Diagnosed with prostate cancer&#xD;
&#xD;
          3. Electing to undergo robotic assisted laparoscopic prostatectomy (RALP)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age &lt; 18&#xD;
&#xD;
          2. Emergency surgery&#xD;
&#xD;
          3. Patients with a significant preoperative dependence on narcotic medications&#xD;
&#xD;
          4. Unable to give informed consent&#xD;
&#xD;
          5. Dementia, history of dementia, or other significant mental impairment that would, in&#xD;
             the opinion of the investigator, impede patient self-reporting&#xD;
&#xD;
          6. Persons participating in any other research study involving an investigational drug or&#xD;
             device or investigational surgical procedure that could interfere with the physiologic&#xD;
             parameters being collected (for example, a study evaluating different anesthesia&#xD;
             regimens that could confound study results)&#xD;
&#xD;
          7. Non-English-speaking or reading&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Males with prostate cancer who are eligible and electing to undergo robotic assisted laparoscopic prostatectomy (RALP)</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronney Abaza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OhioHealth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dublin Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostatectomy</keyword>
  <keyword>Robotic</keyword>
  <keyword>Urology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

